Chan LK, Wai-Hung Ho D, Kam CS, Yung-Tuen Chiu E, et al. RSK2-inactivating mutations potentiate MAPK signaling and support cholesterol metabolism in hepatocellular carcinoma. J Hepatol 2020 Sep 9. pii: S0168-8278(20)33610.
PMID: 32918955